How should a patient who has been on sertraline for many years, recently reduced from 75 mg to 50 mg, be switched to escitalopram (Lexapro)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 18, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Switching from Sertraline to Escitalopram (Lexapro)

You can directly switch from sertraline 50 mg to escitalopram 10 mg without a washout period or cross-taper, starting escitalopram the day after stopping sertraline. 1

Rationale for Direct Switch

The 2026 American Society of Clinical Psychopharmacology consensus guidelines achieved 100% agreement (with 100% high confidence) that switching between serotonin reuptake inhibitors requires consideration of the half-life of the discontinued medication, but abrupt switching is generally acceptable between SSRIs 1. The panel specifically noted that cross-tapers are generally unnecessary when switching between drugs that inhibit serotonin reuptake, and that concerns about serotonin syndrome from combining two SSRIs are overstated—this complication is "very uncommon" 1.

Specific Switching Protocol

Step 1: Stop Sertraline

  • Discontinue sertraline 50 mg (the patient has already tapered from 75 mg to 50 mg weeks ago)
  • Sertraline has a 24-hour elimination half-life 2, which is relatively short and does not require gradual tapering when switching to another SSRI

Step 2: Start Escitalopram Immediately

  • Begin escitalopram 10 mg once daily the next day (morning or evening, with or without food) 3
  • This is the FDA-recommended initial and therapeutic dose for major depressive disorder 3
  • No washout period is needed between these two SSRIs 1

Monitoring for Withdrawal Symptoms

While direct switching is appropriate, monitor for discontinuation symptoms from sertraline over the first 1-2 weeks:

  • Common symptoms include vertigo, "brain zaps," irritability, anxiety, or flu-like symptoms 1
  • These are typically mild and self-limited when switching between SSRIs
  • The starting of escitalopram should help mitigate most withdrawal effects since both drugs work on the serotonin transporter

Important Caveats

If Withdrawal Symptoms Emerge

  • If intolerable discontinuation symptoms occur, consider briefly resuming sertraline at a lower dose (25 mg) and tapering more gradually over 1-2 weeks before restarting escitalopram 2
  • However, this is rarely necessary when switching between SSRIs at these doses

Dose Titration of Escitalopram

  • Start at 10 mg daily—this is both the initial and recommended therapeutic dose 3
  • Maximum dose is 20 mg daily, but no additional benefits were demonstrated at 20 mg in clinical trials 3
  • If dose adjustment is needed, wait at least 1 week given escitalopram's pharmacokinetics 3

What NOT to Do

  • Do not overlap both medications (taking sertraline and escitalopram simultaneously) as this creates mechanistic redundancy without clear benefit 1
  • Do not use alternate-day dosing when tapering sertraline, as this causes pronounced receptor occupancy variation and increases withdrawal risk 4
  • Do not require a 14-day washout period—this is only necessary when switching to/from MAOIs, not between SSRIs 2

Expected Timeline

  • Week 1-2: Monitor for any sertraline discontinuation symptoms (usually minimal with direct switch)
  • Week 4: Assess initial response to escitalopram 10 mg
  • Week 8: Full therapeutic evaluation; consider dose adjustment only if inadequate response

This direct switching approach minimizes the period without adequate serotonergic coverage while avoiding unnecessary polypharmacy or prolonged tapers that could risk depressive relapse 5.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.